Genomic Prostate Score Does Not Improve Risk Assessment Genomic Prostate Score Does Not Improve Risk Assessment

A genomic prostate score has little value in predicting adverse outcomes in men who have undergone a period of active surveillance before having a radical prostatectomy, according to a study.Medscape Medical News
Source: Medscape Hematology-Oncology Headlines - Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news